{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T08:16:59Z","timestamp":1774081019396,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,10,7]],"date-time":"2014-10-07T00:00:00Z","timestamp":1412640000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1038\/bjc.2014.532","type":"journal-article","created":{"date-parts":[[2014,10,7]],"date-time":"2014-10-07T19:58:29Z","timestamp":1412711909000},"page":"167-170","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Breast cancer incidence and mortality in a transitioning Chinese population: current and future trends"],"prefix":"10.1038","volume":"112","author":[{"given":"I O L","family":"Wong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C M","family":"Schooling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B J","family":"Cowling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G M","family":"Leung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,10,7]]},"reference":[{"issue":"5","key":"BFbjc2014532_CR1","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1093\/eurpub\/ckq120","volume":"21","author":"F Asadzadeh Vostakolaei","year":"2011","unstructured":"Asadzadeh Vostakolaei F, Karim-Kos HE, Janssen-Heijnen ML, Visser O, Verbeek AL, Kiemeney LA (2011) The validity of the mortality to incidence ratio as a proxy for site-specific cancer survival. Eur J Public Health 21 (5): 573\u2013577.","journal-title":"Eur J Public Health"},{"key":"BFbjc2014532_CR2","doi-asserted-by":"publisher","first-page":"c3620","DOI":"10.1136\/bmj.c3620","volume":"341","author":"P Autier","year":"2010","unstructured":"Autier P, Boniol M, LaVecchia C, Vatten L, Gavin A, H\u00e9ry C, Heanue M (2010) Disparities in breast cancer mortality trends between 30 European countries: restrospective trend analysis of WHO mortality database. Br Med J 341: c3620.","journal-title":"Br Med J"},{"issue":"8","key":"BFbjc2014532_CR3","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1093\/aje\/kwi273","volume":"162","author":"A Baker","year":"2005","unstructured":"Baker A, Bray I (2005) Bayesian projections: what are the effects of excluding data from younger age groups? Am J Epidemiol 162 (8): 798\u2013805.","journal-title":"Am J Epidemiol"},{"key":"BFbjc2014532_CR4","first-page":"151","volume":"51","author":"I Bray","year":"2002","unstructured":"Bray I (2002) Application of Markov chain Monte Carlo methods to projecting cancer incidence and mortality. Appl Stat 51: 151\u2013164.","journal-title":"Appl Stat"},{"issue":"1","key":"BFbjc2014532_CR5","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/1097-0215(20000701)87:1<122::AID-IJC18>3.0.CO;2-W","volume":"87","author":"I Bray","year":"2000","unstructured":"Bray I, Brennan P, Boffetta P (2000) Projections of alcohol- and tobacco-related cancer mortality in Central Europe. Int J Cancer 87 (1): 122\u2013128.","journal-title":"Int J Cancer"},{"issue":"1","key":"BFbjc2014532_CR6","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/sj.bjc.6600352","volume":"87","author":"P Brennan","year":"2002","unstructured":"Brennan P, Bray I (2002) Recent trends and future directions for lung cancer mortality in Europe. Br J Cancer 87 (1): 43\u201348.","journal-title":"Br J Cancer"},{"issue":"23","key":"BFbjc2014532_CR7","doi-asserted-by":"publisher","first-page":"3784","DOI":"10.1200\/JCO.2009.26.3756","volume":"28","author":"HJ Burstein","year":"2010","unstructured":"Burstein HJ, Prestrud AA, Seidenfeld J, Anderson H, Buchholz TA, Davidson NE, Gelmon KE, Giordano SH, Hudis CA, Malin J, Mamounas EP, Rowden D, Solky AJ, Sowers MR, Stearns V, Winer EP, Somerfield MR, Griggs JJ (2010) American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer. J Clin Oncol 28 (23): 3784\u20133796.","journal-title":"J Clin Oncol"},{"key":"BFbjc2014532_CR8","unstructured":"Cancer Statistics (2013) \n                    http:\/\/www3.ha.org.hk\/cancereg\/e_a1b.asp\n                    \n                   Accessed November 2013."},{"key":"BFbjc2014532_CR9","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/sim.4780060406","volume":"6","author":"D Clayton","year":"1987","unstructured":"Clayton D, Schifflers E (1987) Models for temporal variation in cancer rates, II: age-period-cohort models. Stat Med 6: 469\u2013481.","journal-title":"Stat Med"},{"key":"BFbjc2014532_CR10","doi-asserted-by":"publisher","first-page":"3670","DOI":"10.1002\/sim.3733","volume":"28","author":"LX Clegg","year":"2009","unstructured":"Clegg LX, Hankey BF, Tiwari R, Feuer EJ, Edwards BK (2009) Estimating average annual per cent change in trend analysis. Stat Med 28: 3670\u20133682.","journal-title":"Stat Med"},{"key":"BFbjc2014532_CR11","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1259\/0007-1285-21-252-583","volume":"21","author":"J Clemmesen","year":"1948","unstructured":"Clemmesen J (1948) Carcinoma of the breast. Br J Radiol 21: 583\u2013590.","journal-title":"Br J Radiol"},{"key":"BFbjc2014532_CR12","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1093\/annonc\/mdq096","volume":"21","author":"RB Costa","year":"2010","unstructured":"Costa RB, Kurra G, Greenberg L, Geyer CE (2010) Efficacy and cardiac safety of adjuvant trastuzumab-based chemotherapy regimens for HER2-positive early breast cancer. Ann Oncol 21: 2153\u20132160.","journal-title":"Ann Oncol"},{"issue":"12","key":"BFbjc2014532_CR13","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/S1470-2045(10)70257-6","volume":"11","author":"J Cuzick","year":"2010","unstructured":"Cuzick J, Sestak I, Baum M, Buzdar A, Howell A, Dowsett M, Forbes JF (2010) Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial. Lancet Oncol 11 (12): 1135\u20131141.","journal-title":"Lancet Oncol"},{"issue":"3","key":"BFbjc2014532_CR14","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1371\/journal.pmed.0030025","volume":"3","author":"S Eaker","year":"2006","unstructured":"Eaker S, Dickman PW, Bergkvist L, Holmberg L The Uppsala\/Orebro Breast Cancer Group (2006) Differences in management of older women influence breast cancer survival: results from a population-based database in Sweden. PLoS Med 3 (3): e25.","journal-title":"PLoS Med"},{"key":"BFbjc2014532_CR15","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","volume":"365","author":"Early Breast Cancer Trialists' Collaborative Group","year":"2005","unstructured":"Early Breast Cancer Trialists' Collaborative Group (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365: 1687\u20131717.","journal-title":"Lancet"},{"key":"BFbjc2014532_CR16","volume-title":"Cancer Incidence, Mortality and Prevalence Worldwide","author":"J Ferlay","year":"2002","unstructured":"Ferlay J, Bray F, Pisani P, Parkin DM GLOBOCAN (2002) Cancer Incidence, Mortality and Prevalence Worldwide IARC CancerBase No. 5, version 2.0 IARC Press: Lyon, (2004)."},{"issue":"4","key":"BFbjc2014532_CR17","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1214\/ss\/1177011136","volume":"7","author":"A Gelman","year":"1992","unstructured":"Gelman A, Rubin DB (1992) Inference from iterative simulation using multiple sequences. Stat Sci 7 (4): 457\u2013511.","journal-title":"Stat Sci"},{"key":"BFbjc2014532_CR18","first-page":"CD003370","volume":"4","author":"L Gibson","year":"2009","unstructured":"Gibson L, Lawrence D, Dawson C, Bliss J (2009) Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women. Cochrane Database Syst Rev 4: CD003370.","journal-title":"Cochrane Database Syst Rev"},{"key":"BFbjc2014532_CR19","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1093\/jnci\/86.17.1336","volume":"86","author":"LJ Herrinton","year":"1994","unstructured":"Herrinton LJ, Standford JL, Schwartz SM, Noel SW (1994) Ovarian cancer incidence among Asian migrants to the United States and their descendants. J Natl Cancer Inst 86: 1336\u20131339.","journal-title":"J Natl Cancer Inst"},{"key":"BFbjc2014532_CR20","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1093\/annonc\/mdn025","volume":"19","author":"C Hery","year":"2008","unstructured":"Hery C, Ferlay J, Boniol M, Autier P (2008) Quantification of changes in breast cancer incidence and mortality since 1990 in 35 countries with Caucasian-majority populations. Ann Oncol 19: 1187\u20131194.","journal-title":"Ann Oncol"},{"key":"BFbjc2014532_CR21","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev.pu.12.050191.002233","volume":"12","author":"T Holford","year":"1991","unstructured":"Holford T (1991) Understanding the effects of age, period and cohort on incidence and mortality rates. Annu Rev Public Health 12: 425\u2013457.","journal-title":"Annu Rev Public Health"},{"key":"BFbjc2014532_CR22","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1177\/096228029200100306","volume":"1","author":"T Holford","year":"1992","unstructured":"Holford T (1992) Analyzing the effects of age, period and cohort on incidence and mortality rates. Stat Methods Med Res 1: 317\u2013337.","journal-title":"Stat Methods Med Res"},{"key":"BFbjc2014532_CR23","unstructured":"Hong Kong Cancer Registry (2013) Hong Kong Cancer Registry \n                    http:\/\/www3.ha.org.hk\/cancereg\/faq.html\n                    \n                   Accessed November 2013."},{"key":"BFbjc2014532_CR24","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","volume":"19","author":"HJ Kim","year":"2000","unstructured":"Kim HJ, Fay MP, Feuer EJ, Midthune DN (2000) Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 19: 335\u2013351, (correction: 2001;2020:2655).","journal-title":"Stat Med"},{"key":"BFbjc2014532_CR25","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1093\/pubmed\/fdn034","volume":"30","author":"GM Leung","year":"2008","unstructured":"Leung GM, Woo PPS, Cowling BJ, Tsang CS, Cheung AN, Ngan HY, Galbraith K, Lam TH (2008) Who receives, benefits from and is harmed by cervical and breast cancer screening among Hong Kong Chinese. J Public Health. 30: 282\u2013292.","journal-title":"J Public Health."},{"key":"BFbjc2014532_CR26","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1023\/A:1023925010837","volume":"14","author":"CK Liao","year":"2003","unstructured":"Liao CK, Rosenblatt KA, Schwartz SM, Weiss NS (2003) Endometrial cancer in Asian migrants to the United States and their descendants. Cancer Causes Control 14: 357\u2013360.","journal-title":"Cancer Causes Control"},{"key":"BFbjc2014532_CR27","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.ctrv.2008.03.013","volume":"34","author":"Y Madarnas","year":"2008","unstructured":"Madarnas Y, Trudeau M, Franek JA, McCready D, Pritchard KI, Messersmith H (2008) Adjuvant \/ neoadjuvant trastuzumab therapy in women with HER-2\/neu-overexpressing breast cancer: a systematic review. Cancer Treat Rev 34: 539\u2013557.","journal-title":"Cancer Treat Rev"},{"key":"BFbjc2014532_CR28","doi-asserted-by":"crossref","unstructured":"Maddison A (2001) The World Economy. A Millennial Perspective. Organisation for Economic Co-operation and Development, Development Centre: Paris, France.","DOI":"10.1787\/9789264189980-en"},{"key":"BFbjc2014532_CR29","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1016\/S0140-6736(00)02277-7","volume":"355","author":"R Peto","year":"2000","unstructured":"Peto R, Boreham J (2000) UK and USA breast cancer deaths down 25% in year 2000 at ages 20-69 years. Lancet 355: 1822.","journal-title":"Lancet"},{"issue":"11","key":"BFbjc2014532_CR30","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1056\/NEJM200103153441101","volume":"344","author":"DJ Slamon","year":"2001","unstructured":"Slamon DJ, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, Fleming T, Eiermann W, Wolter J, Pegram M, Baselga J, Norton L (2001) Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 344 (11): 783\u2013792.","journal-title":"N Engl J Med"},{"key":"BFbjc2014532_CR31","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1111\/1467-9868.00353","volume":"64","author":"DJ Spiegelhalter","year":"2002","unstructured":"Spiegelhalter DJ, Best NG, Carlin BP, van der Linde A (2002) Bayesian measures of model complexity and fit. J R Stat Soc B 64: 583\u2013639.","journal-title":"J R Stat Soc B"},{"key":"BFbjc2014532_CR32","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1002\/ijc.22731","volume":"121","author":"IOL Wong","year":"2007","unstructured":"Wong IOL, Cowling BJ, Schooling CM, Leung GM (2007) Age-period-cohort projections of breast cancer incidence in a rapidly transitioning Chinese population. Int J Cancer 121: 1556\u20131563.","journal-title":"Int J Cancer"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc2014532.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2014532","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2014532.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T13:26:09Z","timestamp":1684416369000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc2014532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,7]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["BFbjc2014532"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2014.532","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,7]]},"assertion":[{"value":"9 June 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}